BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 21787222)

  • 1. The role of cytokines in the pathogenesis and treatment of systemic lupus erythematosus.
    Davis LS; Hutcheson J; Mohan C
    J Interferon Cytokine Res; 2011 Oct; 31(10):781-9. PubMed ID: 21787222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies.
    Lu R; Munroe ME; Guthridge JM; Bean KM; Fife DA; Chen H; Slight-Webb SR; Keith MP; Harley JB; James JA
    J Autoimmun; 2016 Nov; 74():182-193. PubMed ID: 27338520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.
    Bolouri N; Akhtari M; Farhadi E; Mansouri R; Faezi ST; Jamshidi A; Mahmoudi M
    Inflamm Res; 2022 Jun; 71(5-6):537-554. PubMed ID: 35298669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological pathogenesis and treatment of systemic lupus erythematosus.
    Pan L; Lu MP; Wang JH; Xu M; Yang SR
    World J Pediatr; 2020 Feb; 16(1):19-30. PubMed ID: 30796732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine disturbances in systemic lupus erythematosus.
    Jacob N; Stohl W
    Arthritis Res Ther; 2011 Jul; 13(4):228. PubMed ID: 21745419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.
    Munroe ME; Vista ES; Guthridge JM; Thompson LF; Merrill JT; James JA
    Arthritis Rheumatol; 2014 Jul; 66(7):1888-99. PubMed ID: 24578190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Novel therapeutic possibilities in systemic lupus erythematosus].
    Bazsó A; Poór G; Gergely P; Kiss E
    Orv Hetil; 2010 May; 151(18):735-40. PubMed ID: 20410000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy.
    Idborg H; Oke V
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of human systemic lupus erythematosus: recent advances.
    Crispín JC; Liossis SN; Kis-Toth K; Lieberman LA; Kyttaris VC; Juang YT; Tsokos GC
    Trends Mol Med; 2010 Feb; 16(2):47-57. PubMed ID: 20138006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in cytokines in cutaneous and systemic lupus erythematosus.
    Mikita N; Ikeda T; Ishiguro M; Furukawa F
    J Dermatol; 2011 Sep; 38(9):839-49. PubMed ID: 21767292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus.
    Peng H; Wang W; Zhou M; Li R; Pan HF; Ye DQ
    Clin Rheumatol; 2013 Sep; 32(9):1255-66. PubMed ID: 23708831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of the immune system in systemic lupus erythematosus.
    Ramanujam M; Davidson A
    Expert Rev Mol Med; 2008 Jan; 10():e2. PubMed ID: 18205972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dysregulation of cytokine networks in systemic lupus erythematosus.
    Apostolidis SA; Lieberman LA; Kis-Toth K; Crispín JC; Tsokos GC
    J Interferon Cytokine Res; 2011 Oct; 31(10):769-79. PubMed ID: 21877904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytokines in systemic lupus erythematosus].
    Robak E; Sysa-Jedrzejowska A; Robak T
    Przegl Lek; 1996; 53(8):623-6. PubMed ID: 8999465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokines and their receptors as biomarkers of systemic lupus erythematosus.
    Suh CH; Kim HA
    Expert Rev Mol Diagn; 2008 Mar; 8(2):189-98. PubMed ID: 18366305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into the pathogenic role of neutrophils in systemic lupus erythematosus.
    Ma S; Jiang W; Zhang X; Liu W
    Curr Opin Rheumatol; 2023 Mar; 35(2):82-88. PubMed ID: 36255744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches.
    Lazar S; Kahlenberg JM
    Annu Rev Med; 2023 Jan; 74():339-352. PubMed ID: 35804480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progranulin Mediates Proinflammatory Responses in Systemic Lupus Erythematosus: Implications for the Pathogenesis of Systemic Lupus Erythematosus.
    Jing C; Zhang X; Song Z; Zheng Y; Yin Y
    J Interferon Cytokine Res; 2020 Jan; 40(1):33-42. PubMed ID: 31804874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.